good buying @ 4.1c, but not a huge fan of market depth, too easily manipulated, price/volume action is what really counts, imho.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025